HB 485 Delaware House · 151st General Assembly (2021-2022)

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO CHILDHOOD LEAD POISONING PREVENTION.

Summary
This Act continues work started with the passage of HB 222 to ensure blood lead tests for school, child care, and early intervention programs enrollment meet standards and allow for the efficient transmission of blood lead screen data to schools, child care facilities, and early intervention service providers to provide a better opportunity to assist children with different levels of lead exposure. The Act defines the requirement for both a 12-month and a 24-month screening for children enrolled in child care facilities, public and private schools, and early intervention programs while clarifying the failure to obtain a 12-month screening does not prevent enrollment for children who provide proof of a 24-month screening. The Act also establishes requirements making blood lead level data available to school nurses and special education coordinators.
Bill status in committee 1 of 4 stages cleared
Introduction
Jun 2022
Committee Review
Floor Vote
Governor
Introduced Jun 16, 2022 Last action Jun 29, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
1
Committee
1
Jun 29, 2022
Introduced
Assigned to Appropriations Committee in House
lower
Jun 21, 2022
Lower · Passed
Reported Out of Committee (Health & Human Development) in House with 4 Favorable, 4 On Its Merits
lower
Jun 16, 2022
Introduced
Introduced and Assigned to Health & Human Development Committee in House
lower
3 primary · 12 co-sponsors

Sponsors